PATENT CLAIM ANALYSIS

Application Number: 16101251
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-04
Patent Classification: ["546", "275400"]

Abstract:
Disclosed herein are processes for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde (also referred to herein as Compound (I)) and intermediates used in such processes. Compound (I) binds to hemoglobin and increases it oxygen affinity and hence can be useful for the treatment of diseases such as sickle cell disease.

Claim (Index 38):
The compound of  claim 37 , wherein each R is independently \u2014CH(CH 3 )\u2014O\u2014CH 2 CH 3  or \u2014CH(CH 2 CH 3 )\u2014O\u2014CH 2 CH 3 .

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.48837
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15593198', '14559786', '14236362', '15748212', '15705104']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7623055095808776
- 35 USC 102 Novelty (BERT): 0.5317694513742622
- Combined Prediction Score: 0.7392519037602161
- Mean Citation Score: 208.76494
- Max Citation Score: 331.12485
- Similarity Product: 160.14309591181575

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test